Valmark Advisers Inc. Takes Position in Health Catalyst, Inc. (NASDAQ:HCAT)

Valmark Advisers Inc. purchased a new position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 130,000 shares of the company's stock, valued at approximately $1,204,000. Valmark Advisers Inc. owned 0.23% of Health Catalyst at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Semanteon Capital Management LP purchased a new stake in Health Catalyst during the fourth quarter worth about $197,000. New York State Common Retirement Fund increased its stake in Health Catalyst by 1.3% during the fourth quarter. New York State Common Retirement Fund now owns 122,967 shares of the company's stock worth $1,139,000 after purchasing an additional 1,582 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Health Catalyst by 23.0% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,072 shares of the company's stock worth $140,000 after purchasing an additional 2,817 shares during the period. Mackenzie Financial Corp purchased a new stake in Health Catalyst during the fourth quarter worth about $172,000. Finally, Perigon Wealth Management LLC grew its position in shares of Health Catalyst by 34.1% during the fourth quarter. Perigon Wealth Management LLC now owns 40,697 shares of the company's stock worth $377,000 after buying an additional 10,355 shares in the last quarter. 85.00% of the stock is currently owned by hedge funds and other institutional investors.

Health Catalyst Stock Performance

Shares of Health Catalyst stock traded up $0.43 during trading hours on Friday, hitting $6.03. 692,662 shares of the company were exchanged, compared to its average volume of 583,214. The company has a current ratio of 4.42, a quick ratio of 4.42 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $353.12 million, a price-to-earnings ratio of -2.87 and a beta of 1.29. Health Catalyst, Inc. has a 1 year low of $5.45 and a 1 year high of $14.37. The business has a 50-day moving average of $7.39 and a 200-day moving average of $8.25.

Health Catalyst (NASDAQ:HCAT - Get Free Report) last posted its quarterly earnings data on Thursday, February 22nd. The company reported ($0.21) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.06. The business had revenue of $75.08 million for the quarter, compared to analyst estimates of $73.67 million. Health Catalyst had a negative return on equity of 12.19% and a negative net margin of 39.92%. As a group, analysts expect that Health Catalyst, Inc. will post -0.47 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently commented on HCAT. Barclays began coverage on Health Catalyst in a research report on Wednesday, January 3rd. They set an "overweight" rating and a $14.00 price objective for the company. Piper Sandler reissued an "overweight" rating and set a $15.00 price objective (down from $17.00) on shares of Health Catalyst in a research report on Friday, February 23rd. Guggenheim raised Health Catalyst from a "neutral" rating to a "buy" rating and set a $14.00 price target for the company in a report on Friday, January 26th. Canaccord Genuity Group lowered their price target on Health Catalyst from $12.00 to $11.00 and set a "buy" rating for the company in a report on Friday, February 23rd. Finally, KeyCorp reaffirmed a "sector weight" rating on shares of Health Catalyst in a report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $12.10.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.